What are the treatment options
Dual agonist (Tirzepatide): Mentioned earlier, tirzepatide (Lilly) is a single peptide that activates both the GLP-1 and GIP (Glucose-dependent Insulinotropic Polypeptide) receptors
For researchers considering a switch from semaglutide to tirzepatide , the 10mg dose is often the target maintenance level after completing the escalation schedule
Cryo-EM maps have been deposited in the Electron Microscopy Data Bank under the following accession codes: for the CagriCTRG s complex, EMD-64557 (raw map), EMD-64558 (receptor-focused refinement map), and EMD-64560 (composite map)
Evidence in one sentence: Both delivery systems are biologically plausible and supported by limited human biomarker or pharmacokinetic data, but neither has been proven superior for meaningful clinical outcomes
40 mg/mL: the ultra-concentrated formulation At 40 mg/mL, 10 units delivers a full 4.0 mg of tirzepatide